The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Risk-benefit assessment of ivabradine in the treatment of chronic heart failure
|
|---|---|
| Published in |
Drug, Healthcare and Patient Safety, April 2014
|
| DOI | 10.2147/dhps.s43275 |
| Pubmed ID | |
| Authors |
Irmina Urbanek, Krzysztof Kaczmarek, Iwona Cygankiewicz, Pawel Ptaszynski |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 3 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 43 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 9 | 21% |
| Student > Master | 6 | 14% |
| Other | 5 | 12% |
| Researcher | 4 | 9% |
| Student > Ph. D. Student | 4 | 9% |
| Other | 7 | 16% |
| Unknown | 8 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 23 | 53% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 12% |
| Economics, Econometrics and Finance | 2 | 5% |
| Agricultural and Biological Sciences | 2 | 5% |
| Arts and Humanities | 1 | 2% |
| Other | 2 | 5% |
| Unknown | 8 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 May 2014.
All research outputs
#16,868,837
of 25,584,565 outputs
Outputs from Drug, Healthcare and Patient Safety
#110
of 156 outputs
Outputs of similar age
#138,386
of 239,569 outputs
Outputs of similar age from Drug, Healthcare and Patient Safety
#5
of 6 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 239,569 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one.